Medivation (Nasdaq:MDVN) is a biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies.
Recent Mentions on Fool.com
- Keep an Eye on Ligand, Medivation, ChemoCentryx, and Teva Today
- Are Doctors Shifting From Johnson & Johnson's Zytiga to Medivation's Xtandi?
- When Japanese Pharma Report, These American Biotechs React
- Manufacturing Sold Separately? Dendreon's Plan B.
- Alexion's Breakthrough Bounce Leads Biotech's Tepid Weekly Gains